ClinicalTrials.gg

Program

tonlamarsen

Also written as “Tonlamarsen” and “ION904”.

Its studies are mostly in Hypertension · Hypertensive Crisis, led by 2 companies.

Furthest: phase 2, since Mar 29, 20224 company-led studies, 1 open or runningNext primary completion: Dec 2026 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Ionis Pharmaceuticals20 open or runningphase 2since Mar 29, 2022Jan 26, 2021none ahead
Kardigan21 open or runningphase 2since Feb 12, 2025Feb 12, 2025Dec 2026phase 2 · NCT07511361

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jan 26, 2021First study: phase 1 study in HypertensionNew to Ionis PharmaceuticalsIonis Pharmaceuticals · NCT04731623 · 40 enrolled · Canada
  2. Mar 29, 2022Phase 2 study in HypertensionIonis Pharmaceuticals · NCT05314439 · 48 enrolled · United States
  3. Feb 12, 2025Kardigan's first study: phase 2 study in HypertensionNew to KardiganKardigan · NCT06864104 · 206 enrolled · United States
  4. Mar 28, 2026Phase 2 study in HypertensionKardigan · NCT07511361 · 140 planned · United States

Ahead

  1. Dec 2026Primary completion: phase 2 study in HypertensionKardigan · NCT07511361

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07511361Hypertension · United States2RecruitingKardiganDec 2026140
NCT06864104Hypertension · United States2CompletedKardiganJan 12, 2026206
NCT05314439Hypertension · United States2CompletedIonis PharmaceuticalsJan 31, 202348
NCT04731623Hypertension · Canada1CompletedIonis PharmaceuticalsAug 12, 202140

How it is read

Names in the registry

  • “Tonlamarsen”, 2 entries
  • “ION904”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.